Related Experiment Videos
A report on 341 six-antigen matched transplants
Insights
Six-antigen matched kidney transplants significantly improve graft survival rates, even in highly sensitized patients or those with extended cold ischemia times. This highlights the benefit of precise donor-recipient matching for better transplant outcomes.
Area of Science:
- Nephrology
- Transplantation immunology
- Organ transplantation
Background:
- Kidney transplantation is a vital treatment for end-stage renal disease.
- Graft survival remains a challenge, influenced by factors like donor-specific antibodies and ischemia time.
- Optimizing donor-recipient matching is crucial for improving long-term graft function.
Purpose of the Study:
- To evaluate the impact of six-antigen matched kidney transplants on graft survival.
- To compare outcomes between matched and unmatched kidney transplants.
- To assess the efficacy of matched transplants in sensitized patient populations.
Main Methods:
- Retrospective analysis of kidney transplant recipients.
- Comparison of one-year graft survival rates between six-antigen matched and control groups.
- Analysis of outcomes stratified by cold ischemia time and patient sensitization levels.
Main Results:
- One-year graft survival was 90% for six-antigen matched transplants versus 78% for controls.
- Matched transplants showed 90% survival with >30 hours cold ischemia, compared to 80% for controls with <30 hours.
- In sensitized patients, one-year graft survival was 92% for matched transplants versus 72% for controls.
Conclusions:
- Six-antigen matching significantly enhances one-year kidney graft survival.
- Matched transplants offer superior outcomes irrespective of cold ischemia time or recipient sensitization.
- This matching strategy is particularly beneficial for highly sensitized patients, improving transplant success rates.
Abstract:
1. One-year graft survival for patients receiving 6-antigen matched transplants was 90% compared to 78% for control nonshipped, nonmatched kidneys. 2. Graft survival with more than 30 hours of cold ischemia time was 90% for 6-antigen matched transplants compared to 80% for control transplants with short cold ischemia times of less than 30 hours. 3. Among 188 paired kidneys in which 1 kidney was shipped and transplanted into a 6-antigen matched patient, the 1-year graft survival was 87% compared to 75% for the contralateral, nonshipped kidney. 4. Almost 40% of 6-antigen matched transplants were performed in sensitized patients. As many as 13% of the 6-antigen matched kidneys were grafted into highly sensitized patients. The 1-year graft survival of 32 patients with antibodies reactive to more than 80% of the random panel was 92% compared to 72% for transplants in similarly sensitized controls.